NCT02668640View on ClinicalTrials.gov

Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

May 1, 2016

Primary Completion Date

June 12, 2018

Study Completion Date

August 13, 2018

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

Adalimumab

Pre-filled syringe, administered by subcutaneous injection

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY